Investors

Dr. Ashleys Limited is a global pharmaceutical company, together with its subsidiaries, specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (API) and Orphan Drugs. The company also offers Contract Research and Manufacturing Services (CRAMS).

Founded in 2012, our mission is to deliver life-saving drugs to underserved markets while maintaining profitability. We are committed to producing affordable APIs and Orphan Drugs for rare diseases, targeting the epicenter of various health challenges.

With centers in four countries, we distribute over 85 products to over 80 countries.